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Abstract
Background: Candida species is the third commonest cause of  sepsis among neonates. Colonization by Candida 
is a predictor for candidemia among preterm neonates.
Objectives:  To  determine  prevalence  of   early  Candida  colonization  and  early  outcome among colonized 
preterm neonates admitted to Mulago hospital Special Care Unit.
Methods: A prospective observational cohort was conducted between December 2008 and April 2009. Preterm 
neonates  aged >72 hours  and less than one week were screened  for Candida colonization of  the groin, oral 
pharynx and rectum using CHROMagar. Colonized neonates were followed up for 14 days. Blood cultures were 
done for those with signs of  septicaemia.
The Fisher’s exact tests and logistic regression were conducted for factors associated with colonization  and mor-
tality among colonized neonates. P values of  < 0.05 were considered significant and confidence interval of  95% 
was used.
Results: Candida colonization  occurred in 50/213 (23.5%) neonates. Gestational age ≤ 30 weeks was the only 
factor independently  associated with colonization  (p = 0.005). Of  the colonized 14/46 (30.4%) died and 13/46 
(28.3%) developed mucocutaneous candidiasis. No candidemia was identified. Multiple site colonization was inde-
pendently associated with mortality (p=0.035).
Conclusion: The consequence of  high colonization observed in this study needs to be further elucidated in 
Uganda.
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Introduction
The majority of  global neonatal deaths take place in low 
income countries2 with the leading causes being prema-
turity (28%) and infections (26%)2,3. In Uganda infec-
tions and preterm births account for 31% and 25% of  
all neonatal deaths respectively4,5. Although Candida 
species exist as commensals on the skin, oropharynx 
and gastrointestinal tract, invasive candidiasis7-9 may oc-
cur among preterm neonates due to immaturity of  their 
immune system6,7.
Surveys from some parts of  the world have revealed 
an increase in occurrence of  invasive candidiasis in ne-
onatal intensive care units (NICUs) especially among 
preterm neonates8-10 with outbreaks reported from 
some NICUs11. Studies have found that 7-20% of  all 
Candida colonized  preterm  neonates develop invasive 
candidiasis12-15 and  the  most  important predictor  for 
invasive  candidiasis  in neonates  is colonization  by 
Candida10,13,16. Invasive candidiasis is associated with 
substantial morbidity as well as a high attributable mor-
tality rate (range, 30–75%)16.
Early  diagnosis  of   invasive  candidiasis  is challenging 
hence  the  shifting  of   the  focus  to prevention.   Two 
different   Cochrane   reviews   analyzing   antifungal 
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prophylaxis   using oral/topical  nystatin/miconazole 
and  systemic  fluconazole  among  very  low  birth 
weight neonates have demonstrated a reduction in inva-
sive fungal disease among infants receiving anti-fungal 
prophylaxis 17,18.
In this paper, we describe Candida colonization and 
candidemia in preterm neonates. Since there  was  no 
data  on  the  prevalence  and  outcome  of   Candida 
colonization  of   preterm neonates  in  our  settings, 
our  study  findings  will  provide  guidance  for  care 




Study Site: This study was conducted at the Special 
Care Unit (SCU) in Mulago hospital. Mulago  hospital 
is  a  national  referral  hospital  for  Uganda  and  a 
teaching  hospital  for Makerere University.  The SCU is 
where newborn babies who require specialized care are 
admitted. The unit admits over 2000 low birth weight 
babies per year with a 35% mortality among low birth 
weight babies . The unit has preterm, full term and 
Kangaroo Mother Care sections.
Most  invasive  procedures  are  not  carried  out  in  the 
unit  and  the  available  maximum respiratory  support 
is  Continuous  Positive  Airway  Pressure  (CPAP).  The 
unit  is  over crowded with most incubators shared by 2 
to 3 preterm neonates.
Preterm  neonates  are  discharged  from  SCU  once 
they  are  tolerating  oral  feeds,  gaining weight and 
maintaining stable body temperature while in Kangaroo 
care irrespective of  their weight  or gestational  age.  A 
Kangaroo  clinic  runs  in the  unit twice  a week.  Dis-
charged neonates are followed up from this clinic till 
they attain a weight of  2500g.
Study design and sample size: 
This was a prospective observational cohort study.
Sample size for prevalence using Kish Leslie method 
was used since prevalence of  Candida colonization was 
the primary objective. Because no such study had been 
conducted in Uganda; results from a study in India that 
found 15.5% preterm neonates colonized by day 3 of  
life15 was used in estimating sample size and assuming: 
Z-Standard normal value corresponding to 95% confi-
dence interval (1.96)
D-Absolute errors between the estimated and true val-
ue= 0.05 (5%). P- The prevalence of  Candida coloniza-
tion of  (15.5%) after 72 hours of  life. n = Z2 P (1-P)  / 
D2n = 1.962 x 0.155(1- 0.155)    / 0.052         n (Sample 
size required) = 201 
Assuming 6% loss to follow up: Final sample size = 213
Procedures: Eligible neonates were those < 37weeks of  
gestational age who were > 72 hours and  <  7  days 
old.  Gestational  ages  were  determined  using  New 
Ballard  Score  (NBS) performed within 24 hours of  
admission.
Mothers of  eligible neonates were identified; detailed 
explanation given and written consent obtained prior to 
enrolment. Neonates born to mothers who had been on 
antifungal agents in the last month of  pregnancy were 
excluded. Enrolled neonates were given study numbers 
and data captured using pre-coded case report forms.
The study staff  used sterile swabs to collect specimens 
from the groin,  oral pharynx  and rectum by gently 
rubbing without prior use of  antiseptic. Different 
swabs were used for each site. The swabs  were  placed 
in Amies  transport  medium,  labeled  with participants 
study number and site of  collection and transported to 
the laboratory immediately. Specimens were inoculated 
on CHROMagar  (Becton Dickinson,  Sparks MD) and 
incubated at 370C. Agar plates were examined at the 
microbiology laboratory (Department of  Microbiology 
Makerere University) for growth at 24, 48 and 72 hours. 
Candida albicans was identified using CHROMagar 
while  for  non  albicans  fermentation  of   sugars  (Glu-
cose,  Sucrose,  Lactose, Maltose and Urase) was used.
Colonized neonates were followed-up for two weeks at 
the SCU and for those discharged earlier  as outpatients. 
Parents  to neonates  discharged  before  laboratory  re-
sults  were  back were traced in the follow-up clinic on 
their scheduled visit.
During the follow-up neonates were examined for oral 
or perianal thrush and for signs suggestive of  septicae-
mia by World Health Organization criteria1. Neonates 
with oral thrush received nystatin suspension and clotri-
mazole cream for those with diaper rash. 
 
Blood was collected under aseptic technique from neo-
nates with signs of  septicaemia, placed in  blood  cul-
ture  bottles  with  Brain  heart  infusion  agar  and 
transported  to laboratory  for Candida and bacterial 
isolation.
Data management and analysis: Data from case re-
port forms was entered into EPI DATA package  3.1 
then exported  into STATA  version  10 for analysis. 
Univariate  analysis  was conducted  for  continuous 
variables  (gestation  ages,  birth  weight  and  moth-
ers’  ages)  and results summarized as mean, median and 
standard deviations.
Continuous  variables  were  categorized  and  then  ana-
lyzed  using  Fisher’s  exact  test  to determine associa-
tion with Candida colonization. Factors with p value ≤ 
0.2 in the bivariate analysis were included in the logistic 
regression model to determine factors independently 
associated with colonization. P values of  < 0.05 were 
considered significant and confidence interval of  95% 
was used.
Ethical approval: Approval to carry out this study was 
granted by the Research and Ethics Committee of  Mak-
erere University Medical School. 
Results
Over  a  five  months  period  (December  2008  to 
April  2009),  213  preterm  neonates  were enrolled in 
the study. Four study participants were discharged early 
and lost to follow up. Table 1 shows baseline character-
istics  of  study participants. The mean gestational age 
and birth weight of  the study participants  were 31.6 
weeks (SD 2.3) and 1469 gms (SD 303) respectively. 
Forty  (18.8%)  of   the  study  participants  were  small 
for  gestational  age.  All participants received intrave-
nous ampicillin and gentamicin prophylactically;  92% 
received continuous  positive  airway  pressure  and 32% 
received  intravenous  aminophylline.  Breast milk  feeds 
were  initiated  in 93%  of   the  study  participants  prior 
to  enrollment.  Two (2) participants  received ibupro-
fen for patent ductus ateriosus and none received sur-
factant or parenteral lipids. No participant underwent 
central venous catheterization or intubation and none 
had commenced kangaroo care prior to enrollment.
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Table 1. Baseline characteristics of the 213 study participants at admission.  
Variables                                                          Frequency                               Percentage 
                                                                                (213)                                          (%)                                                                                                                                                                                      
Sex 
               Male                                                           101                                           47.7 
              Female                                                       112                                           52.3 
Place of birth 
               Mulago                                                       138                                          64.8 
              Other health facility                                    52                                           24.4 
              Home                                                           23                                          10.8 
Mode of delivery 
              Vaginal                                                        174                                          82.0 
              Caeserian section                                         39                                          18.0 
HIV exposure 
                 Not exposed                                             175                                           82.2 
               Exposed                                                      38                                           17.8 
Gestation Age 
                31-36 weeks                                             150                                          70.4 
                 ≤30 weeks                                                 63                                          29.6              
Birth weights 
              ≤ 1500 grams                                              126                                           59.2 
             > 1500 grams                                                87                                           40.8  
Axillary temperature (oC) 
               < 36.5                                                       207                                           97.0     
                ≥36.5                                                           6                                             3.0                                                    
Respiratory rate (breaths/min) 
                < 60                                                         167                                           78.4 
                ≥ 60                                                           46                                           21.6 
Pulse rate (beats/min) 
             ≥ 120                                                          194                                           91.1 
             < 120                                                            19                                             8.9                              




Baseline characteristics were taken at admission
The mean age of  the mothers involved in the study 
was 24 years (SD 5.5). Thirty six mothers (18.8 %) were 
HIV positive, eight were on HAART and 19 (53%) were 
on cotrimoxazole prophylaxis only. No mother had 
received antenatal steroids or antifungal treatment in 
the last month of  pregnancy. Seventy eight percent of  
mothers reported using herbs all of  which were taken 
orally and no mother reported use of  herbs per vagina. 
Table 2 shows Candida species and sites of  coloniza-
tion.  Fifty (23.5%) of  the 213 enrolled preterm neo-
nates were colonized.   The   rectum   was   the   most 
colonized   site.   Eighteen   (36%)   neonates   had 
colonization  of  more than one site and two had all the 
three sites colonized.  Four of  the colonized neonates 
had more than one species of  Candida.
Table 3 shows association between baseline charac-
teristics, interventions and early Candida colonization. 
No association was found between interventions  re-
ceived prior to enrollment and  colonization.   From 
multiple  regression  analysis  gestational  age  ≤  30 
weeks  was significantly associated with colonization 
(p= 0.005). During follow-up, 13/46 (28%) of  the col-
onized neonates developed mucocutaneous candidiasis 
(oral +/- diaper) occurring between day 6 and 12 of  
life. Nine (20%) of  the colonized neonates developed 
clinical sepsis, seven had  confirmed  bacterial  septicae-
mia;  Klebsiella  pneumonia  (5),  Eschericia  coli  (1) 
and Serratia marcescens  (1) while two had no isolated 
organisms.  Candidemia  was not found among  these 
neonates.  Both  neonates  who  had  clinical  septicae-
mia  with  negative  blood cultures had more than one 
site colonized and one neonate developed mucocutane-
ous candidiasis.
Table  2. Candida species  and  sites of   colonization   
Organisms n=70 (%) Oral n = 6 Groin n = 29 Rectal n = 35 
Candida albicans 28 (40%) 2 12 14 
Candida krusei 21 (30%) 0 10 11 
Candida glabrata 13 (18.6) 2 6 5 
Candida tropicalis 2 (2.9%) 0 1 1 
Unidentified 6 (8.5%) 2 0 4 
Four of the colonized preterm neonates had more than one species of Candida, 2 had krusei + albicans, 1 
had glabrata + albicans and 1 had glabrata + tropic 
Table 3 Association between baseline characteristics, interventions and early Candida 
colonization  
Variables Candida colonization 




Sex    
Male 78 (47.8%) 23 (46%) 0.93 0.818 
Female 85 (52.2%) 27 (54%) (0.46-1.84)  
Place of birth     
Mulago 108 (66.3%) 30 (60%) 1.00 0.444 
Other health facility 36 (22%) 16 (32%) (0.30-3.30)  
Home 19 (11.7%) 4 (8%)   





















Exposed 33 (20.0%) 5 (10%) (0.13-1.23)  
Gestational age     
31-36 weeks 123 (81.0%) 27 (54%) 2.60 0.004 
≤ 30 weeks 40 (19.0%) 23 (46%) (1.20-5.30)  
Birth weight     
≤ 1500grams 90 (55.2%) 36 (72%) 2.08 0.047 
> 1500grams 73 (44.8%) 14 (28%) (1.00-4.50)  
Duration of rupture of     
Membranes     
< 24hours 125(77.0%) 38 (76%) 1.03 0.920 
≥ 24 hours 38 (23.0%) 12 (24%) (0.44-2.28)  
Oral Suction*     
No 148 (91.0%) 48 (96%) 0.41 0.371 
Yes 15(9.0%) 2 (4%) (0.04-1.87)  
CPAP     
No 151(92.7%) 46 (92%) 1.09 1.000 
Yes 12(7.3%) 4 (8%) (0.24-3.84)  
Initiation of breast milk     
Yes 155(95.1%) 45 (90%) 2.15 0.190 
No 8(4.9%) 5 (10%) (0.52-7.86)  
Small for gestational age     
Yes 32 (19.6%) 8 (16.0%) 0.82 0.773 
No 131 (80.4%) 42 (84.0%) (0.42-1.64)  
Variable COR* p-value AOR* p-value 
 (95% CI)  (95% CI)  
Gestational age 2.619 0.004 2.60 0.005 
≤ 30 weeks (1.27- 5.33)  (1.33-5.10)  
HIV exposure 0.437 0.138 0.45 0.116 
 (0.13-1.23)  (0.16-1.22)  
Not Initiated on 2.153 0.190 1.04 0.994 
Breast milk (0.52-7.86)  (0.3-3.5)  
  
* Preterm neonates delivered from other health facilities; if suction was not mentioned then it was assumed not done. 
COR* Crude Odds ratio, AOR* Adjusted Odds Ratio
African Health Sciences Vol 15 Issue 1, March 2015African Health Sciences Vol 15 Issue 1, March 2015          200 201
Out of   46  colonized  neonates  14  (30%)  died.  Eight 
died  from  septicaemia,  four  from suspected necrotiz-
ing  enterocolitis  (NEC), and two from aspiration  of  
feeds. All neonates who died from suspected NEC had 
Candida rectal colonization, three had more than one 
site colonized, and two of  them had mucocutaneous 
candidiasis.   All neonates who died from suspected 
NEC, deteriorated  following  rapid progression  of  
suspected  NEC, no blood for cultures were obtained 
and parents declined postmortem.  Table 4 shows fac-
tors associated with  mortality  among  Candida  colo-
nized  neonates.  There  was  no  association  between 
Candida species responsible for colonization with oc-
currence of  mucocutaneous candidiasis, bacterial sep-
ticaemia or death. On logistic regression association 
between multiple sites of  Candida colonization  and 
mortality remained statistically significant p=0.035 al-
though the numbers were small.
Discussion
The prevalence of  Candida colonization observed of  
23.5% is comparable to 26.2% that was observed by 
Mandiratta et al in India during the first week of  life15 
but higher than those observed in other centers19-21. 
Our prevalence might actually be an under estimation 
since we did not screen for colonization prior to 72 
hours of  life yet studies we are comparing with screened 
study  subjects  from  the  first  24  hours  of   life.    Al-
though  other  studies  did  not describe the day to 
day activities of  their units, SCU is small, overcrowded 
with sharing of  incubators and mothers are involved in 
the nursing care. These factors can potentiate person to 
person transmission  of  Candida since horizontal trans-
mission  has been shown to be an equally important 
route of  Candida acquisition22,23.
Gestational  age  ≤ 30  weeks  was  the  only  factor 
independently  associated  with  Candida colonization 
(p=0.005). This finding is similar to the findings from 
other studies15,20,21. The association of  Candida coloni-
zation and lower gestational age is partly due to pre-
maturity being associated with compromised immunity 
6,7. The other explanation for this association may lie in 
the excessive handling that preterm neonates inevitably 
undergo while in neonatal units that promotes horizon-
tal acquisition23. There was no association observed be-
tween small  for gestational  age  study  participants  and 
Candida  colonization  (p=0.82),  no  other studies that 
we came across looked at small for gestational age and 
colonization. Our study finding is contrary to knowl-
edge that these neonates are susceptible to infections 
due to some degree of  immunosuppression24.  One 
possible explanation for lack of  association may be that 
the small for gestational age neonates tend to be stable 
hence have less frequent handling and therefore lower 
risk of  horizontal acquisition of  Candida. 
 
In  our  study  the  odds  of   being  colonized  with  Can-
dida  when  a  neonate  was  delivered vaginally was 1.5 
fold higher than by caesarian section, however this was 
not statistically significant (p = 0.411). Findings from 
other studies demonstrated vaginal delivery as being 
associated with Candida colonization15,21,23.   The lack 
of  statistical significance found in our study may be at-
tributed to Prolonged Rupture of  Membranes (PROM) 
≥24 hours which occurred in 41% of  the mothers who 
delivered by caesarian section and because we did not 
screen for colonization within first 24 hours, some of  
the admitted neonates who died at less than 72 hours of  
age might have been colonized.
After controlling for PROM, the association  of  colo-
nization  and vaginal delivery was not statistically  sig-
nificant  (p=0.389).  This  supports  the  possibility  that 
Candida  colonization identified after 72 hours of  life is 
more likely acquired from the environment22,23.
PROM  for  ≥  24  hours  has  been  associated   with 
ascending  infections   and  neonatal septicaemia. In 
this study there was no association between PROM and 
Candida colonization (p= 1.000). This finding corre-
lates  with findings  from other studies20,21  but contrary 
to findings by Mandiratta  et al which found a signifi-
cant association  (p=<0.05)(15).  Although they didn’t 
specify hours of  rupture of  membranes,  Mandiratta 
et al screened mothers for Candida vaginal coloniza-
tion and found 29.8% of  mothers were colonized with 
some isolated species resembling those responsible for 
neonatal colonization. Maternal HIV has been associ-
ated    with   higher   vaginal   Candida    colonization 
especially    as   the   mothers’ immunological  state dete-
riorates25. The association  between HIV exposure and 
Candida colonization was not statistically significant (p 
= 0.138) even after controlling for mode of  delivery 
(p=0.124). The possible explanation is that most of  
the HIV infected mothers were receiving HIV care and 
possibly their immunological status were good hence 
less carriage of  Candida. 
 
Interventions  received prior to enrollment  were not 
associated  with Candida colonization. The odds of  be-
ing colonized if  breast milk had not been initiated was 
2.15(95% CI, 0.525-7.866)  although  it  was  not  statis-
tically  significant  (p  =  0.190).  This  finding  could  be 
attributed to the presence of  lactobacillus in the breast 
milk that has been demonstrated to reduce gut Candida 
colonization in preterm neonates26,27.
Mucocutaneous Candidiasis occurred in 28% of  colo-
nized neonates between the 6th and 12th day of  life. 
These findings were similar to those observed in other 
studies one describing mucocutaneous  candidiasis in 
a third of  colonized neonates20 and another describing 
the time  of   occurrence  as  2nd  to  3rd   week  of  
life28.  Although  other  studies  have  reported can-
didemia in 7-20% of  colonized preterm neonates, in 
our study, we did not find any. This may be due to the 
fact that our study did not have extremely premature 
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  Table 4. Bivariate and multivariate analysis of Factors associated with mortality among  
  Candida colonized preterm neonates. 
  Variable                                        N=46 (%)                             COR *                 p-value  
                                                 Died                 Alive 
                                               (N=14)              (N=32)                 (95% CI) 
  Sites colonized† 
  > 1site                                   9(64.3%)            7(22%)                    6.4                      0.0084 
     1 site                                  5(35.7%)          25(78%)               (1.34-32.15)                                                                                                                                                             
  Mucocutaneous  
  Candidiasis 
  Yes                                          2(14.3%)          11(34.4%)               0.32                   0.286                     
  No                                         12(85.7%)          21(65.6%)           (0.03-1.89)  
  Bacterial septicaemia 
  Yes                                          6(43%)               1(3.1%)               23.0                     0.0019 
  No                                           8(57%)             31(96.9%)           (2.14-1102) 
  Gestation age 
  ≤ 30 weeks                            12(85.7%)          10(31.3%)              13.2                    0.001                  
  31-36weeks                             2 (14.3%)         22(68.7%)           (2.17-134.5)  
  C. Albican colonization* 
  Yes                                          8(61.5%)          13(46.6%)               1.84                   0.505 
  No                                           5(38.5%)          15(53.6%)           (0.40-8.99)  
  C. Krusei  colonization* 
  Yes                                          4(31%)             13(46.4%)               0.51                   0.498   
  No                                           9(69%)             15 (53.6%)          (0.094-2.44) 
  C. Non-albican & non- krusei* 
  Yes                                          2(15.4%)            3(10.7%)               1.51                   0.645 
  No                                          11(84.6%)          25(89.3%)           (0.11-15.1)                                                                                                                                                            
 
Variable                                  COR*                p-value                 AOR *              p-value             
                                              (95%CI)                                          (95% CI)                    
 
> 1 site colonized                    6.242                   0.0084                   6.41                    0.035                
                                              ( 1.34-32.1)                                     (1.143-36.0)            
  Gestation age ≤ 30weeks          13.2                  0.001                    7.07                     0.044                
                                              (2.17-134.5)                                    (1.057-47.3)          
  Bacterial septicaemia                23                    0.0019                    9.4                       0.08              
COR* Denotes Crude Odds Ratio, AOR* denotes Adjusted Odds Ratio 
4 preterm neonates were lost to follow up. † 2 preterm neonates who were lost to follow up had >1 site colonized. 
* 5 of the colonized preterm neonates had species that were not identified; they were excluded from analysis for association between 
Candida species colonized with and outcome 
  
 
neonates who are more susceptible and the unit does 
minimal invasive procedures hence minimizing risk for 
Candidemia.  Although studies have shown that multi-
ple body site colonization with Candida is  associated 
with  candidemia13,29,  our  study  did  not  find  this 
association.  However, mortality was significantly asso-
ciated with more than one site colonization. The main 
cause of  mortality among our study neonates was bac-
terial sepsis; the factors predisposing these neonates to 
bacterial sepsis may be the same factors that predispose 
them to early Candida colonization30.
The study limitations  included  an underestimated 
prevalence  since  we did not screen  for colonization 
within 24 hours of  life. Our data was skewed with the 
majority of  our study subjects being >30 weeks gesta-
tion, since most of  the extremely preterm neonates in 
our unit do  not  survive  beyond  72  hours  of   life. 
The  study  was  not  powered  enough  to  study asso-
ciations  and our inability to do postmortem  on study 
participants  who died especially those with suspected 
NEC might have compromised identification of  inva-
sive candidiasis.
Conclusion: In view of  the perceived threat of  Can-
didemia among this population with the high coloni-
zation and low levels of  candidemia observed in this 
study, the consequence of  early colonization needs to 
be further elucidated in Uganda
What is already known on this subject
Candida colonization among preterm neonates is a pre-
dictor for invasive candidiasis. Antifungal prophylaxis 
among preterm neonates effectively reduces fungal col-
onization and invasive disease.
What this study adds
Early Candida colonization of  preterm neonates in a 
low-resource setting is very prevalent. Candidemia is 
not common.
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